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1177into the pathogenesis of heart disease in patients
treated for HIV infection. Lipodystrophy can indeed
lead to ectopic spillover of triglyceride into non-
adipose tissues—including the myocardium—and has
previously been associated with adverse LV remod-
eling (2). Furthermore, that HAART exposure also
predicted myocardial triglyceride content and LV
dysfunction provides further insight into the
pathogenesis of heart disease in HIV(þ) patients.
For example, HAART has been associated with
lipodystrophy, hyperlipidemia, and hyperglycemia
(4) and may be directly cardiotoxic (5). Thus,
whereas HAART has signiﬁcantly reduced HIV-
related morbidity and mortality, we speculate that
HAART may also contribute to the cardiovascular
decline in HIV(þ) patients. Future studies are
warranted to further investigate these ﬁndings.Michael D. Nelson, PhD
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2004;4:327–37.A Comprehensive Evaluation of Left
Atrial Performance Using Volumetric
Analysis, Strain, and Strain Rate ImagingWe read with great interest the article by Habibi et al.
(1), which demonstrates the association of left atrial
(LA) function and the development of heart failure
using cardiac magnetic resonance (CMR) feature-
tracking. We fully agree that LA function
assessment has the potential to gain an incremental
role in the early diagnosis and risk stratiﬁcation
already at pre-clinical stages of heart failure (2).
As correctly cited by the investigators, LA
echocardiographic speckle tracking studies (3) have
demonstrated that a comprehensive assessment of LA
deformation should include strain and strain rate
parameters to describe the 3 functional components of
atrial physiology: 1) reservoir function (collection of
pulmonary venous return during ventricular systole—
assessed with global peak longitudinal strain and global
peak positive strain rate); 2) conduit function (passage of
blood to the left ventricle during early ventricular
diastole—assessed with global passive longitudinal strain
and global peak early negative strain rate); and 3)
contractile booster pump function (augmentation of
ventricular ﬁlling during late ventricular diastole—
assessed with global longitudinal strain during atrial
contraction and global peak late negative strain rate).
Furthermore, when using CMR, an atrial volumetric
analysis is also well established to assess these 3
functional components (4).
Habibi et al. (1) have now applied CMR feature-tracking
strain—but not strain rate—to assess LA reservoir and
contractile booster pump function without studying
conduit function. Conversely, they used volumetric
indices to study LA reservoir and conduit function but
not contractile booster pump function. It is important to
note that there is evidence to suggest that impaired LA
contractile booster pump function assessed with
volumetric analysis has strong prognostic implications
for adverse cardiac events (including development of
heart failure) in asymptomatic patients at risk for left
ventricular diastolic dysfunction (5).
A more comprehensive analysis including all atrial
deformation parameters (strain and strain rate) and
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1178volumetric indices for all 3 phases of atrial physiology
and the study of their prognostic implications would
have been desirable to indicate which parameters
are best to assess when studying atrial physiology
with CMR.Johannes Tammo Kowallick
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of Left Atrial Performance Using Volumetric
Analysis, Strain, and Strain Rate ImagingWe appreciate the interest shown by Drs. Kowallick
and Schuster in our article (1). Both volumetric and
deformational analysis methods have been used to
assess phasic left atrial (LA) function. Volumetric
method enables measuring passive, active, and total
LA emptying fractions, which are representatives of
conduit, booster pump, and global/reservoir phase
functions, respectively (2). In parallel, phasic LA
strain and strain rate are also representatives of
phasic LA function as correctly explained by Drs.
Kowallick and Schuster. Feature-tracking cardiac
magnetic resonance (CMR) has the ability to assess
LA function using both volumetric and deformational
analysis methods. Our ﬁndings in measuring phasic
LA strain rate using feature-tracking on steady state
free precession cine sequences have been promising(3). However, in this study, the images were acquired
using fast gradient echo protocol with a temporal
resolution of w50 ms, which is not desirable for
calculating strain rate. We would also like to point
out that the images were acquired between 2000 and
2002, when cine CMR sequences with higher
temporal resolution were still in development.
However, as suggested by Drs. Kowallick and
Schuster, we calculated LA active emptying fraction
using previously described method (4). As expected,
LA active emptying fraction at baseline was
signiﬁcantly lower in heart failure cases than in
control cases (27  10% vs. 32  11%; p < 0.001). In
multivariable analysis, after adjusting for traditional
cardiovascular risk factors, as explained in our
article (1), the magnitude of LA active emptying
fraction was associated with reduced incident heart
failure (odds ratio: 0.62 per SD, 95% conﬁdence
interval: 0.46 to 0.83). However, similar to LA
passive emptying fraction, after additionally
adjusting for left ventricular mass and N-terminal
pro–B-type natriuretic peptide, the association
became insigniﬁcant.
On the basis of the study population and outcome
variable, the association of phasic LA function with
cardiovascular events may vary. As mentioned by
Drs. Kowallick and Schuster, in a study on 210 hyper-
tensive patients among all CMR-measured volumetric
LA parameters, active emptying fraction had the
strongest association with major adverse cardiac
events including heart failure, but also all-cause mor-
tality, myocardial infarction, and unstable angina (4).
However, about one-half of our study population did
not have the diagnosis of hypertension, and we
focused on incident heart failure as the only outcome.
Finally, to our knowledge, this study is the ﬁrst
to examine the association of LA function measured
with feature-tracking CMR and incident heart
failure in the general population. Future studies to
compare the prognostic role of phasic LA function for
different types of adverse cardiac events will be of
great value.Mohammadali Habibi, MD
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